Skip to Main Content

Paper Details

Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial.
Int J Radiat Oncol Biol Phys
5
2023
Author NameAffiliation
Daniel E SprattUniversity Hospitals Seidman Cancer Center
Jeff M MichalskiWashington University
Elai Davicioni
Alejandro BerlinPrincess Margaret Cancer Centre, Cancer Clinical Research Unit
Phuoc T TranUniversity of Maryland
Howard M SandlerCedars-Sinai Medical Center
Eric VigneaultCHU de Quebec Universite Laval
Felix Y FengUniversity of California San Francisco
  • 1 - 8

Datasets

Release 1.2